Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,299 | 109 | 49.0% |
| Travel and Lodging | $3,298 | 12 | 49.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139.99 | 7 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $2,324 | 16 | $0 (2018) |
| Boston Scientific Corporation | $1,700 | 13 | $0 (2024) |
| EMD Serono, Inc. | $1,141 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $185.21 | 7 | $0 (2024) |
| GENZYME CORPORATION | $161.06 | 9 | $0 (2019) |
| Lilly USA, LLC | $140.62 | 4 | $0 (2019) |
| Acorda Therapeutics, Inc | $139.99 | 7 | $0 (2019) |
| Biogen, Inc. | $129.04 | 7 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $122.33 | 2 | $0 (2017) |
| GE HEALTHCARE | $103.76 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,461 | 21 | Boston Scientific Corporation ($839.56) |
| 2023 | $379.07 | 7 | EMD Serono, Inc. ($337.30) |
| 2022 | $124.32 | 3 | EMD Serono, Inc. ($87.29) |
| 2020 | $402.33 | 2 | Boston Scientific Corporation ($387.46) |
| 2019 | $1,171 | 37 | Boston Scientific Corporation ($472.97) |
| 2018 | $1,538 | 25 | Medtronic USA, Inc. ($1,251) |
| 2017 | $1,661 | 33 | Medtronic USA, Inc. ($1,073) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neurology | ||||||
| 11/12/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $106.71 | General |
| Category: Neurology | ||||||
| 10/13/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $58.14 | General |
| Category: Vercise_NMD | ||||||
| 10/12/2024 | Boston Scientific Corporation | Vercise (Device) | Travel and Lodging | In-kind items and services | $122.23 | General |
| Category: Vercise_NMD | ||||||
| 10/11/2024 | Boston Scientific Corporation | Vercise (Device) | Travel and Lodging | In-kind items and services | $300.11 | General |
| Category: Vercise_NMD | ||||||
| 10/11/2024 | Boston Scientific Corporation | Vercise (Device) | Travel and Lodging | In-kind items and services | $232.64 | General |
| Category: Vercise_NMD | ||||||
| 10/11/2024 | Boston Scientific Corporation | Vercise (Device) | Travel and Lodging | In-kind items and services | $104.14 | General |
| Category: Vercise_NMD | ||||||
| 09/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $52.31 | General |
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Neuropsychiatry | ||||||
| 09/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| 09/05/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 08/28/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Immune | ||||||
| 06/27/2024 | Boston Scientific Corporation | Bionic Navigator (Device) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: Bionic Navigator_NMD | ||||||
| 06/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2024 | Boston Scientific Corporation | Bionic Navigator (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Bionic Navigator_NMD | ||||||
| 06/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $96.16 | General |
| 03/13/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Immunology | ||||||
| 03/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $48.55 | General |
| Category: Neurology | ||||||
| 02/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $148.93 | General |
| Category: Neurology | ||||||
| 01/25/2024 | Boston Scientific Corporation | Bionic Navigator (Device) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Bionic Navigator_NMD | ||||||
| 08/30/2023 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $41.77 | General |
| Category: Neurology | ||||||
| 07/26/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $88.40 | General |
| 07/25/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $99.57 | General |
| Category: Neurology | ||||||
| 05/09/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $74.35 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 401 | 459 | $84,708 | $24,673 |
| 2022 | 3 | 480 | 560 | $101,935 | $33,488 |
| 2021 | 7 | 671 | 736 | $134,444 | $47,784 |
| 2020 | 8 | 646 | 729 | $130,364 | $39,890 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 150 | 192 | $37,596 | $10,646 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 157 | 172 | $23,058 | $6,224 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 67 | 67 | $17,213 | $5,849 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 13 | $3,722 | $1,339 | 36.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 15 | 15 | $3,119 | $614.78 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 235 | 298 | $56,096 | $18,488 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 97 | 97 | $24,838 | $8,204 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 148 | 165 | $21,001 | $6,796 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 161 | 161 | $41,442 | $15,388 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 173 | 211 | $38,434 | $13,552 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 257 | 282 | $34,840 | $12,219 | 35.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 17 | 17 | $5,908 | $2,363 | 40.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 22 | 24 | $6,389 | $2,353 | 36.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 22 | 22 | $4,574 | $966.68 | 21.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 19 | 19 | $2,857 | $942.15 | 33.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 241 | 290 | $47,246 | $15,384 | 32.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 142 | 142 | $39,032 | $12,553 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 138 | 153 | $17,370 | $5,218 | 30.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2020 | 33 | 33 | $12,765 | $2,712 | 21.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 12 | 29 | $6,593 | $2,328 | 35.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 19 | 19 | $3,950 | $811.26 | 20.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 36 | 38 | $2,652 | $687.71 | 25.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Facility | 2020 | 25 | 25 | $757.00 | $197.20 | 26.1% |
About Dr. Jean Thomas, MD
Dr. Jean Thomas, MD is a Neurology healthcare provider based in Lewiston, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881695534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jean Thomas, MD has received a total of $6,737 in payments from pharmaceutical and medical device companies, with $1,461 received in 2024. These payments were reported across 128 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,299).
As a Medicare-enrolled provider, Thomas has provided services to 2,198 Medicare beneficiaries, totaling 2,484 services with total Medicare billing of $145,835. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Lewiston, ID
- Active Since 08/03/2005
- Last Updated 12/26/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1881695534
Products in Payments
- ACTIVA (Device) $2,324
- Vercise (Device) $817.26
- GENERAL DBS (Device) $472.97
- GENERAL - DBS (Device) $387.46
- Mavenclad (Drug) $304.19
- MAVENCLAD (Drug) $248.90
- INGREZZA (Drug) $185.21
- Rebif (Biological) $166.80
- AMPYRA (Drug) $103.12
- ONZETRA Xsail (Drug) $100.00
- TYSABRI (Biological) $86.26
- AUBAGIO (Drug) $74.65
- Mavenclad (Biological) $72.32
- LEMTRADA (Drug) $67.03
- APTIOM (Drug) $65.60
- LYRICA (Drug) $63.23
- GILENYA (Drug) $58.45
- VYVGART HYTRULO (Drug) $41.77
- VYVGART (Drug) $39.46
- SOLIRIS (Drug) $38.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lewiston
Dr. Baljinder Singh, M.d, M.D
Neurology — Payments: $71,043
Dr. Carl Robinson, Md, MD
Neurology — Payments: $7,252
Dr. David Burke, Md, MD
Neurology — Payments: $3,751
Dr. Mark Keane, M.d, M.D
Neurology — Payments: $495.11
Dr. Bradley Truax, M.d, M.D
Neurology
Dr. Elizabeth Doherty, M.d, M.D
Neurology